Sapporo City General Hospital

Sapporo 060-8604

1 studies enrolling now · 6 studies all time

What they study most

Immunoglobulin A Nephropathy, Lupus Erythematosus, Systemic, Multiple Myeloma, Rheumatoid Arthritis

Studies at this site

• A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide — Running, not enrolling
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
• A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed